Unknown

Dataset Information

0

Oncogenic dependency on β-catenin in liver cancer cell lines correlates with pathway activation.


ABSTRACT: Hepatocellular carcinoma (HCC) represents a serious public health challenge with few therapeutic options available to cancer patients.Wnt/β-catenin pathway is thought to play a significant role in HCC pathogenesis. In this study, we confirmed high frequency of CTNNB1 (β-catenin) mutations in two independent cohorts of HCC patients and demonstrated significant upregulation of β-catenin protein in the overwhelming majority of HCC patient samples, patient-derived xenografts (PDX) and established cell lines. Using genetic tools validated for target specificity through phenotypic rescue experiments, we went on to investigate oncogenic dependency on β-catenin in an extensive collection of human HCC cells lines. Our results demonstrate that dependency on β-catenin generally tracks with its activation status. HCC cell lines that harbored activating mutations in CTNNB1 or displayed elevated levels of non-phosphorylated (active) β-catenin were significantly more sensitive to β-catenin siRNA treatment than cell lines with wild-type CTNNB1 and lower active β-catenin. Finally, significant therapeutic benefit of β-catenin knock-down was demonstrated in established HCC tumor xenografts using doxycycline-inducible shRNA system. β-catenin downregulation and tumor growth inhibition was associated with reduction in AXIN2, direct transcriptional target of β-catenin, and decreased cancer cell proliferation as measured by Ki67 staining. Taken together, our data highlight fundamental importance of aberrant β-catenin signaling in the maintenance of oncogenic phenotype in HCC.

PROVIDER: S-EPMC5777711 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC8435276 | BioStudies
| S-EPMC4839611 | BioStudies
| S-EPMC8217095 | BioStudies
| S-EPMC3446854 | BioStudies
| S-EPMC6826293 | BioStudies
| S-EPMC8018973 | BioStudies
2016-01-01 | S-EPMC4735788 | BioStudies
| S-EPMC2693754 | BioStudies
2014-01-01 | S-EPMC4453854 | BioStudies
| S-EPMC8656042 | BioStudies